Clinical trial

A Phase IV Study of Dimethyl Fumarate Enteric-coated Capsules for Relapsing Multiple Sclerosis (RMS)

NCT07138833

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2025-09-01

PhasePHASE4

Study timeline

Study start (estimated)2025-09-01Date precision: month

Registry last updated2025-08-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Relapsing Multiple Sclerosisunresolved

Interventions

Dimethyl Fumarate Enteric-coated CapsulesDRUG

Sponsors & collaborators

Qilu Pharmaceutical (Hainan) Co., Ltd.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07138833 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.